{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:54:52Z","timestamp":1771955692535,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.5664\/jcsm.9610","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:01:43Z","timestamp":1629208903000},"page":"2543-2555","source":"Crossref","is-referenced-by-count":20,"title":["Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea"],"prefix":"10.1007","volume":"17","author":[{"given":"Sarah","family":"Ronnebaum","sequence":"first","affiliation":[{"name":"OPEN Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Bron","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipen","family":"Patel","sequence":"additional","affiliation":[{"name":"OPEN Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Menno","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shay","family":"Bujanover","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kratochvil","sequence":"additional","affiliation":[{"name":"OPEN Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Lucas","sequence":"additional","affiliation":[{"name":"OPEN Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Stepnowsky","sequence":"additional","affiliation":[{"name":"University of California at San Diego, La Jolla, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"e_1_3_3_2_2","volume-title":"International Classification of Sleep Disorders.","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3rd ed. Darien, IL : American Academy of Sleep Medicine ; 2014 .","edition":"3"},{"key":"e_1_3_3_3_2","unstructured":"National Institute for Health and Care Excellence (NICE)\n. Continuous positive airway pressure for the treatment of obstructive sleep apnoea\/hypopnoea syndrome. \nhttps:\/\/www.nice.org.uk\/guidance\/ta139\n. Accessed November 18 2020."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7640"},{"issue":"8","key":"e_1_3_3_5_2","first-page":"1311","article-title":"Obstructive sleep apnea is a common disorder in the population\u2014a review on the epidemiology of sleep apnea","volume":"7","author":"Franklin KA","year":"2015","unstructured":"Franklin KA, Lindberg E . Obstructive sleep apnea is a common disorder in the population\u2014a review on the epidemiology of sleep apnea . J Thorac Dis. 2015 ; 7 ( 8 ): 1311 \u2013 1322 .","journal-title":"J Thorac Dis."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12039"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00016808"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws342"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3181c99505"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.6.791"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.3.363"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7624"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27662"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5834"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27497"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2018.1541742"},{"issue":"84","key":"e_1_3_3_17_2","first-page":"S130","article-title":"The use of stimulants, sedative-hypnotics, and antidepressants in patients with obstructive sleep apnea in the United States","volume":"22","author":"Ohayon MPJ","year":"2018","unstructured":"Ohayon MPJ, Gibson SP, Scheckner B, Milesi C . The use of stimulants, sedative-hypnotics, and antidepressants in patients with obstructive sleep apnea in the United States . Ann Neurol Suppl. 2018 ; 22 ( 84 ): S130 .","journal-title":"Ann Neurol Suppl."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.6.667"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2017.03.019"},{"key":"e_1_3_3_20_2","unstructured":"U.S. Food & Drug Administration\n. NDA Approval for Sunosi (solriamfetol) in Narcolepsy and Obstructive Sleep Apnea March 20 2019\n. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2019\/211230Orig1s000 %20Orig2s000ltr.pdf\n. Accessed November 18 2020."},{"key":"e_1_3_3_21_2","unstructured":"U.S. Food & Drug Administration\n. Supplemental NDA Approval for Provigil (Modafinil) Tablets in Obstructive Sleep Apnea\/Hypopnea Syndrome and Shift Work Sleep Disorder January 23 2004\n. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2004\/20717se1-008ltr.pdf\n. Accessed November 18 2020."},{"key":"e_1_3_3_22_2","unstructured":"U.S. Food & Drug Administration\n. NDA Approval for Nuvigil (Armodafinil) in Obstructive Sleep Apnea\/Hypopnea Syndrome Narcolepsy and Shift Work Sleep Disorder June 15 2007\n. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2007\/021875s000ltr.pdf\n. Accessed November 18 2020."},{"key":"e_1_3_3_23_2","unstructured":"Sunosi TM (solriamfetol) tablets Summary of Product Characteristics. Dublin Ireland: Jazz Pharmaceuticals Ireland Ltd; 2020."},{"key":"e_1_3_3_24_2","unstructured":"European Medicines Agency\n. Questions and Answers on the Review of Medicines Containing Modafinil [EMEA\/H\/A-31\/1186]. \nhttps:\/\/www.ema.europa.eu\/en\/documents\/referral\/questions-answers-review-medicines-containing-modafinil-re-examination_en.pdf\n. Accessed November 18 2020."},{"key":"e_1_3_3_25_2","unstructured":"Sunosi. Package insert. Jazz Pharmaceuticals Inc; 2019\n."},{"key":"e_1_3_3_26_2","unstructured":"Provigil. Package insert. Teva Pharmaceuticals USA Inc; 2019\n."},{"key":"e_1_3_3_27_2","unstructured":"Nuvigil. Package insert. Teva Pharmaceuticals USA Inc; 2019\n."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_3_3_30_2","unstructured":"Ades AE Caldwell DM Reken S Welton NJ Sutton AJ Dias S\n. Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer\u2019s Checklist. NICE Decision Support Unit Technical Support Document No. 7. \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK395872\/\n. Accessed August 25 2021."},{"key":"e_1_3_3_31_2","unstructured":"National Institute for Health and Care Excellence (NICE)\n. Single Technology Appraisal: User Guide for Company Evidence Submission Template. \nhttps:\/\/www.nice.org.uk\/process\/pmg24\/resources\/single-technology-appraisal-user-guide-for-company-evidence-submission-template-pdf-72286715419333\n. Accessed November 18 2020."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.01.011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.04.002"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.01.004"},{"key":"e_1_3_3_35_2","unstructured":"Cochrane Handbook version 5.1.0. Risk of Bias Tool. http:\/\/handbook-5-1.cochrane.org\/chapter_8\/8_assessing_risk_of_bias_in_included_studies.htm\n. Accessed November 18 2020."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008929526011"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.4.464"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.2912"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.9.2103032"},{"key":"e_1_3_3_40_2","unstructured":"Balk E Earley A Patel K Trikalinos T Dahabreh I\n. Empirical Assessment of Within-Arm Correlation Imputation in Trials of Continuous Outcomes. Agency for Healthcare Research and Quality. \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK115797\/\n. Accessed November 18 2020."},{"key":"e_1_3_3_41_2","unstructured":"Higgins J Thomas J eds. Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 [updated \n2019\n]. \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK395872\/\n. Accessed August 25 2021."},{"key":"e_1_3_3_42_2","unstructured":"National Institute for Health and Care Excellence (NICE)\n. NICE Decision Support Unit Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. \nhttp:\/\/nicedsu.org.uk\/wp-content\/uploads\/2017\/05\/TSD2-General-meta-analysis-corrected-2Sep2016v2.pdf\n. Accessed November 18 2020."},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27393"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-006-0072-z"},{"key":"e_1_3_3_45_2","unstructured":"Jazz Pharmaceuticals 14-003\/TONES 3 trial data on file (Unpublished data)."},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(03)00108-4"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.06.007"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.013"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1100OC"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2015.10.005"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01509-2015"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.02.004"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5096"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.2165\/11315280-000000000-00000"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.11.2.193"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27935"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:59Z","timestamp":1770110219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.9610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.5664\/jcsm.9610"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.9610","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}